Edgewise Therapeutics, Inc.

NASDAQ:EWTX

14.45 (USD) • At close August 27, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -36.115-40.798-39.662-34.129-31.497-28.525-30.143-25.713-21.469-22.838-19.415-17.498-16.067-14.66-12.696-12.949-10.353-6.815-6.342-3.642-3.954-3.185
Depreciation & Amortization 0.5670.5540.6290.6020.5340.5250.5330.4970.4610.2410.0920.1650.1540.1270.0780.0640.0510.0790.050.050.0450.04
Deferred Income Tax 000000-3.32.1841.11600000-4.630000000
Stock Based Compensation 7.7339.0597.7376.885.2244.8715.1534.5594.0113.8373.7363.1732.0371.9781.8731.5480.6870.2960.190.070.0490.045
Change In Working Capital -2.564-4.7586.9412.5133.193-2.319-0.2010.974-0.342-1.9915.5222.035-2.784-0.6871.3263.075-0.1540.3831.4640.25-0.1250.361
Accounts Receivables 0000000000000000000000
Change In Inventory 0000000000000000000000
Change In Accounts Payables -0.1512.8580.092-1.0281.8930.78-1.3821.762-0.312-0.160.5760.938-2.6551.1881.551-0.5241.69-0.0630.1370.205-0.2790.458
Other Working Capital -2.413-7.6166.8493.5411.3-3.0991.181-0.788-0.03-1.8314.9461.097-0.129-1.875-0.2253.599-1.8440.4461.3270.0450.154-0.097
Other Non Cash Items -2.203-1.923-2.602-3.24-3.553-3.151.128-4.559-4.011-2.075-1.7550.1270.4150.674.632.2-0.9010.5170.1370.205-0.2790.458
Operating Cash Flow -32.582-37.866-26.957-27.374-26.099-28.598-26.83-22.058-20.234-22.826-11.82-11.998-16.245-12.572-9.419-8.262-9.769-6.057-4.638-3.272-3.985-2.739
Investing Activities:
Investments In Property Plant And Equipment -0.05-0.044-0.274-0.52-0.221-0.297-0.161-0.457-0.759-4.368-3.293-1.33-0.554-0.369-0.079-0.451-0.076-0.0620-0.006-0.188-0.009
Acquisitions Net 000000-0.027-0.024-0.004-0.0530.0720.025-0.00107.20000000
Purchases Of Investments -263.762-122.18-63.178-45.319-40.955-327.603-39.786-84.667-114.455-16.958-146.691-67.99-63.751-13.956-15.044-41.357-167.091-64.711-24.178000
Sales Maturities Of Investments 101.646166.12284.37471.20178.54459.59266.93108.543118.65670.36874.38842.99964.25945.71129.24410.27.200000
Other Investing Activites 0000000.0270.0240.0040.053-0.072-0.0250.00131.755-7.2-31.1577.2-64.711-24.178000
Investing Cash Flow -162.16643.89820.92225.36237.368-268.30826.98323.4193.44249.042-75.596-26.321-0.04631.38614.121-31.608-159.967-64.773-24.178-0.006-0.188-0.009
Financing Activities:
Debt Repayment 0000000000-0.0350.0350000000000
Common Stock Issued 187.3622.2233.1573.2852239.14752.618-0.2110.3690.021-0.555129.720.1790.0730.2930.037-0.896187.0510000
Common Stock Repurchased 0000000000000000000000
Dividends Paid 0000000000000000000000
Other Financing Activities 0.5980242.0420.048-0.0481.9260.36900.3690.0210.252-0.0650.1790.0730.2930.0370.007-0.10195.00125.1420.1350
Financing Cash Flow 188.2312.2232.8953.3331.952241.07352.987-0.2110.3690.021-0.338129.7250.1790.0730.2930.037-0.896186.9595.00125.1420.1350
Other Information:
Effect Of Forex Changes On Cash 0000000020.4340000000000000
Net Change In Cash -6.5178.255-3.141.32113.221-55.83353.141.15-16.42326.237-87.75491.406-16.11218.8874.995-39.833-170.632116.1266.18521.864-4.038-2.748
Cash At End Of Period 43.40449.92141.66644.80643.48530.26486.09732.95731.80748.2321.993109.74718.34134.45315.56610.57150.404221.036104.91638.73116.86720.905